CUV 6.00% $14.58 clinuvel pharmaceuticals limited

new potential cure for skin cancer, page-3

  1. 648 Posts.
    It was posted just for general interest. Not to compare it to afamelanotide.

    BTW, Clinuvel is years (and I mean years) away from getting the drug approved by the regulators strictly as a cancer prophylactic. The former mgmt team already tried that route in their strategy.

    Yes, the regulators should approve it as a skin cancer prophylactic. But, even though it is a common sense cause and effect link, the regulators will not at this time approve it merely as a prophylactic against skin cancer.

    That kind of proof will take many years. Doubt me on this? Ask them directly.

    So, I wouldn't get all warm and fuzzy about this being approved as a cancer preventative anytime soon. It should, but it won't. Our only hope for broad usage approval is PLE and having the regulators loosen up a bit on a broader PLE usage (where most type I's and some type II's could finagle a PLE diagnosis from their dermatologist).
 
watchlist Created with Sketch. Add CUV (ASX) to my watchlist
(20min delay)
Last
$14.58
Change
-0.930(6.00%)
Mkt cap ! $730.1M
Open High Low Value Volume
$15.35 $15.74 $14.23 $4.173M 285.1K

Buyers (Bids)

No. Vol. Price($)
1 500 $14.56
 

Sellers (Offers)

Price($) Vol. No.
$14.58 1486 2
View Market Depth
Last trade - 16.10pm 09/07/2024 (20 minute delay) ?
CUV (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.